These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 6267130)
1. Induction of complement receptor expression in cell lines derived from human undifferentiated lymphomas. II. Characterization of the induced complement receptors and demonstration of the simultaneous induction of EBV receptor. Magrath I; Freeman C; Santaella M; Gadek J; Frank M; Spiegel R; Novikovs L J Immunol; 1981 Sep; 127(3):1039-43. PubMed ID: 6267130 [TBL] [Abstract][Full Text] [Related]
2. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers. Magrath IT; Freeman CB; Pizzo P; Gadek J; Jaffe E; Santaella M; Hammer C; Frank M; Reaman G; Novikovs L J Natl Cancer Inst; 1980 Mar; 64(3):477-83. PubMed ID: 6243722 [TBL] [Abstract][Full Text] [Related]
3. Complement receptor expression by neoplastic and normal human cells. Gaither TA; Magrath IT; Berger M; Hammer CH; Novikovs L; Santaella M; Frank MM J Immunol; 1983 Aug; 131(2):899-905. PubMed ID: 6306108 [TBL] [Abstract][Full Text] [Related]
4. Induction of complement receptor expression cell lines derived from human undifferentiated lymphomas. I. Mode of action of theophylline and inhibition by certain purines. Magrath I; Freeman C; Novikovs L J Immunol; 1981 Sep; 127(3):1034-8. PubMed ID: 6267129 [No Abstract] [Full Text] [Related]
5. Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule. Atkinson JP; Jones EA J Clin Invest; 1984 Nov; 74(5):1649-57. PubMed ID: 6334100 [TBL] [Abstract][Full Text] [Related]
6. Induction of complement receptors in human cell lines derived from undifferentiated lymphomas. Jaffe ES; Smith SA; Magrath IT; Freeman CB; Alabaster O; Sussman EH Lab Invest; 1981 Sep; 45(3):295-301. PubMed ID: 7278135 [TBL] [Abstract][Full Text] [Related]
7. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines. Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208 [TBL] [Abstract][Full Text] [Related]
8. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains. Klein G; Ehlin-Henriksson B; Schlossman SF J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235 [TBL] [Abstract][Full Text] [Related]
9. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4). Wilson AB; Prichard-Thomas S; Lachmann PJ; Coombs RR Immunology; 1980 Feb; 39(2):195-202. PubMed ID: 7380467 [TBL] [Abstract][Full Text] [Related]
10. Use of fluoresceinated complement-coated bacteria and sheep erythrocyte-antibody-complement complexes for identification of complement receptors on lymphoid cell lines: differences in binding characteristics between cell lines of normal and malignant origin. Benjamin D; Magrath IT; Freeman CB J Natl Cancer Inst; 1983 Nov; 71(5):897-902. PubMed ID: 6316012 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies. Dobson NJ; Lambris JD; Ross GD J Immunol; 1981 Feb; 126(2):693-8. PubMed ID: 7005341 [No Abstract] [Full Text] [Related]
12. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils. Gerdes J; Klatt U; Stein H Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397 [TBL] [Abstract][Full Text] [Related]
13. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers. Zeuthen J; Klein G; Ber R; Masucci G; Bisballe S; Povey S; Terasaki P; Ralph P J Natl Cancer Inst; 1982 Feb; 68(2):179-95. PubMed ID: 6278187 [TBL] [Abstract][Full Text] [Related]
14. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript. Sinha SK; Todd SC; Hedrick JA; Speiser CL; Lambris JD; Tsoukas CD J Immunol; 1993 Jun; 150(12):5311-20. PubMed ID: 8390533 [TBL] [Abstract][Full Text] [Related]
16. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection. Callahan J; Pai S; Cotter M; Robertson ES Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer. Arnaout MA; Melamed J; Tack BF; Colten HR J Immunol; 1981 Oct; 127(4):1348-54. PubMed ID: 7276561 [TBL] [Abstract][Full Text] [Related]
18. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis. Berger M; Fleisher TA J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466 [TBL] [Abstract][Full Text] [Related]
19. Studies of the Epstein-Barr virus receptor found on Raji cells. I. Extraction of receptor and preparation of anti-receptor antibody. Simmons JG; Hutt-Fletcher LM; Fowler E; Feighny RJ J Immunol; 1983 Mar; 130(3):1303-8. PubMed ID: 6337215 [TBL] [Abstract][Full Text] [Related]
20. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns. Klein G; Zeuthen J; Ber R; Ernberg I J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]